Medeor Therapeutics
PrivateLast Round
Grant
Jan 22, 2018
Total Funding Raised
$75.8M
Company Overview
Medeor Therapeutics is a biotechnology company that develops personalized cellular immunotherapies designed to improve outcomes for organ transplant recipients by inducing immune tolerance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medeor Therapeutics Comparables
Compare Medeor Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TolerogenixX GmbH | 89% | |
| Taiwan Bio Therapeutics Inc. | 82% | |
| Sangamo Therapeutics Inc | 77% |
Medeor Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 22, 2018 | ||||
| Series B | Nov 27, 2017 |
Medeor Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series B |
| WuXi Healthcare Ventures | Series B |
| California Institute for Regenerative Medicine | Grant |
| 6 Dimensions Capital | Series B |
| Sofinnova Investments | Series B |
| Vivo Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2026
Monthly visitors increased 110% MoM.
- Mar 3, 2026
Monthly visitors grew 92% MoM.
Medeor Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Medeor Therapeutics's valuation, stock price, and market status.
Is Medeor Therapeutics a public or private company?
Medeor Therapeutics is a private company.
What is the current stock price of Medeor Therapeutics?
Medeor Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Medeor Therapeutics worth (valuation)?
Valuation information for Medeor Therapeutics is not publicly available.
Can I buy Medeor Therapeutics stock?
Medeor Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Medeor Therapeutics's last funding round?
Medeor Therapeutics's most recent funding round was Grant on January 22, 2018.
Who are the main investors in Medeor Therapeutics?
Key investors in Medeor Therapeutics include RA Capital Management.
Will Medeor Therapeutics IPO soon?
No public IPO plans have been announced for Medeor Therapeutics.
How can I track Medeor Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Medeor Therapeutics's secondary market activity and sign up for updates.